ArticleJournal for immunotherapy of cancer2023

Robust IL-2-dependent antitumor immunotherapy requires targeting the high-affinity IL-2R on tumor-specific CD8

Kathryn M LaPorte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.